Document is current
Any future updates will be listed below
-
Authors
Piras, Francesco
Riba, Michela
Petrillo, Carolina
Lazarevic, Dejan
Cuccovillo, Ivan
Bartolaccini, Sara
Stupka, Elia
Gentner, Bernhard
Cittaro, Davide
Naldini, Luigi
Kajaste‐Rudnitski, Anna https://orcid.org/0000-0003-1549-2426
-
Funding
Funding for this research was provided by:
Fondazione Telethon (TGT14D04)
Fondazione Telethon (TELE16C3)
Fondazione Telethon (TGT)
Ministero della Salute (GR‐2009‐1471693)
Fanconi Anemia Research Fund (FARF)
H2020 European Research Council (TARGETINGGENETHERAPY)
- License Information
-
More Information
Article History
Received: 21 April 2017
Revised: 6 June 2017
Accepted: 7 June 2017
First Online: 30 June 2017
Conflict of interest
: AK, FP, BG, and LN are inventors on pending and issued patents on lentiviral vector technology and gene transfer filed by the Salk Institute, Cell Genesys, or Telethon Foundation and San Raffaele Scientific Institute.
